TABLE 4.
Unadjusted Event Rate/100 Patient-Years (No. of Events) | ||
---|---|---|
Endpoint | Rivaroxaban (n ¼ 61) | Warfarin (n ¼ 92) |
Stroke or systemic embolism | 5.0 (3) | 4.1 (4) |
Stroke | 1.6 (1) | 4.1 (4) |
MI | 6.8 (3) | 5.9 (4) |
Vascular death | 3.1 (2) | 11.1 (11) |
Major or NMCR bleeding | 57.7 (15) | 20.3 (12) |
Major bleeding | 15.0 (6) | 8.1 (6) |